BDBM644382 6-chloro-4-(4-{[2-hydroxy-5-(trifluoromethoxy)phenyl]methyl}piperazin-1-yl)-1-methyl-2-oxo-1,2-dihydro-1,5-naphthyridine-3-carbonitrile::US11866430, Example 369

SMILES Cn1c2ccc(Cl)nc2c(N2CCN(Cc3cc(OC(F)(F)F)ccc3O)CC2)c(C#N)c1=O

InChI Key InChIKey=RBKACCDYFNZZSW-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 644382   

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM644382(US11866430, Example 369 | 6-chloro-4-(4-{[2-hydrox...)
Affinity DataIC50: 160nMAssay Description:The compound inhibition studies were carried out as follows: 50 nL droplets of each test compound (top concentration 10 mM with 11 point, 3-fold dilu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2024
Entry Details
US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM644382(US11866430, Example 369 | 6-chloro-4-(4-{[2-hydrox...)
Affinity DataIC50: 2.40E+5nMAssay Description:The compound inhibition studies were carried out as follows: 50 nL droplets of each test compound (top concentration 10 mM with 11 point, 3-fold dilu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2024
Entry Details
US Patent